Ben Ledford, PhD

MR5 Room 3005

MMP-2-Targeted Nanofibers as a Potential Diagnostic and Therapeutic Delivery Vehicle for Abdominal Aortic Aneurysms Abdominal aortic aneurysm (AAA) is the most common aortic pathology, and accounts for ~10,000 deaths/year in the United States. While many preclinical therapeutics have shown promise, … Read More

Miranda Good, PhD

MR5 Room 3005

Sex specific effects of endothelial Pannexin1 in cerebral vascular function and ischemic stroke Our work examines the mechanisms regulating cerebral artery function in health and disease. We examine the role of endothelial Pannexin1, a critical regulator of purinergic signaling, in … Read More

Chastity N. Bradford, PhD

MR5 Room 3005

A Call to Action to Control Hypertension: What will it take to improve health outcomes in medically underserved communities? The research seeks to gain an understanding of the gaps and barriers in medically underserved communities and the effect of their … Read More

Alexandra (Bobbie) Garvin, PhD

MR5 Room 3005

Cardiac Fibroblast Phenotypes: Investigation of the Role of Mitochondrial Structure and Function More than 6 million Americans suffer from heart failure secondary to acute and chronic disease states that induce cardiac fibrosis. Fibrosis is the deposition of extracellular matrix that … Read More

Melissa Luse

MR5 Room 1005

Dynamic nitrosation - palmitoylation of endothelial CD36 regulates serum lipids My talk will focus specifically on a new post-translational modification of a fatty acid translocase CD36 and how this regulates lipid uptake into endothelium.  PhD Candidate Physiology, Isakson Lab, University of … Read More

Scott Johnstone, PhD

MR5 Room 3005

Cell Signaling And Immune Cell Involvement In Neointima Formation Connexin (Cx) proteins form gap junctions, allowing for communication between cells. Alterations in gap junctions have been associated with pathological proliferation in disease since their discovery in the 1950s. Our studies … Read More

Sergio Fazio, MD, PhD

MR5 Room 3005

Toward a Therapy for Atherosclerosis - Discuss growth and composition of the arterial plaque, with possible targets of therapy - Discuss feasibility and drivers of atherosclerosis regression VP/Chair, Scientific Council, Global Clinical Development, Regeneron

Thomas Michel, MD, PhD

MR5 Room 3005

Novel transgenic/chemogenetic models of oxidative stress in the cardiovascular system Dr. Michel’s seminar will discuss the development and application of chemogenetic approaches to dynamically modulate tissue-specific oxidative stress.  These studies have yielded new models of heart failure, neurodegeneration, and aortic … Read More

Jason Fish, PhD

MR5 Room 3005

Extracellular vesicle-mediated communication in cardiovascular disease Extracellular vesicles (EVs) are produced by cells in the cardiovascular system, and they can be taken up by recipient cells to alter function. The contents and functions of EVs change during disease, and they … Read More

Eugene Chen, MD, PhD

MR5 Room 3005

Transgenic Rabbits for Cardiovascular Research and Drug Development Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide. Genome-wide association studies are powerful epidemiological tools to find genes and variants associated with CVD while follow-up biological studies allow … Read More

Matteo Morello, MD and Santosh Karnewar, PhD

MR5 Room 3005

Cavitation Facilitated AAV Transduction This presentation will focus on multidisciplinary collaborative studies between CVRC and BME that investigating how ultrasound cavitation of microbubble contrast agents can produce site-targeted augmentation of AAV to the heart.  These studies are intended to optimize … Read More

Morris White, PhD

MR5 Room 3005

Follistatin mediates MASLD and MASH during hepatic insulin resistance on a high fructose diet MASLD (metabolic dysfunction-associated steatotic liver disease) and its progression to steatohepatitis (MASH) correlates with IR (insulin resistance). However, mice with complete hepatic IR owing to hepatic … Read More